Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 3
2010 2
2011 1
2012 2
2013 1
2014 3
2019 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure.
Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD, Starling RC, Chen L, Boyle AJ, Chillcott S, Adamson RM, Blood MS, Camacho MT, Idrissi KA, Petty M, Sobieski M, Wright S, Myers TJ, Farrar DJ; HeartMate II Clinical Investigators. Slaughter MS, et al. J Heart Lung Transplant. 2010 Apr;29(4 Suppl):S1-39. doi: 10.1016/j.healun.2010.01.011. Epub 2010 Feb 24. J Heart Lung Transplant. 2010. PMID: 20181499
High Transpulmonary Artery Gradient Obtained at the Time of Left Ventricular Assist Device Implantation Negatively Affects Survival After Cardiac Transplantation.
Uriel N, Imamura T, Sayer G, Agarwal R, Sims DB, Takayama H, John R, Pagani FD, Naka Y, Sundareswaran KS, Farrar DJ, Jorde UP; Heartmate II Clinical Investigators. Uriel N, et al. J Card Fail. 2019 Oct;25(10):777-784. doi: 10.1016/j.cardfail.2019.03.010. Epub 2019 Mar 20. J Card Fail. 2019. PMID: 30904557 Clinical Trial.
Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, Massey T, Milano CA, Moazami N, Sundareswaran KS, Farrar DJ; HeartMate II Clinical Investigators. Kormos RL, et al. J Thorac Cardiovasc Surg. 2010 May;139(5):1316-24. doi: 10.1016/j.jtcvs.2009.11.020. Epub 2010 Feb 4. J Thorac Cardiovasc Surg. 2010. PMID: 20132950 Free article.
Neurocognitive assessments in advanced heart failure patients receiving continuous-flow left ventricular assist devices.
Petrucci RJ, Wright S, Naka Y, Idrissi KA, Russell SD, Dordunoo D, Jaski B, Chillcott S, Feldman D, Yanssens T, Heatley G, Koundakjian L, Farrar DJ, Aaronson KD; HeartMate II Clinical Investigators. Petrucci RJ, et al. J Heart Lung Transplant. 2009 Jun;28(6):542-9. doi: 10.1016/j.healun.2009.02.007. J Heart Lung Transplant. 2009. PMID: 19481013 Clinical Trial.
Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
Jorde UP, Kushwaha SS, Tatooles AJ, Naka Y, Bhat G, Long JW, Horstmanshof DA, Kormos RL, Teuteberg JJ, Slaughter MS, Birks EJ, Farrar DJ, Park SJ; HeartMate II Clinical Investigators. Jorde UP, et al. J Am Coll Cardiol. 2014 May 6;63(17):1751-7. doi: 10.1016/j.jacc.2014.01.053. Epub 2014 Mar 5. J Am Coll Cardiol. 2014. PMID: 24613333 Free article. Clinical Trial.
Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device.
Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV; HeartMate II Clinical Investigators. Russell SD, et al. Circulation. 2009 Dec 8;120(23):2352-7. doi: 10.1161/CIRCULATIONAHA.108.814863. Epub 2009 Nov 23. Circulation. 2009. PMID: 19933938 Clinical Trial.
13 results